Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Lakartidningen
|
October 14, 2008
[Non-biased (?) blood pressure experts criticize LFN]
Anders Hernborg
Lakartidningen
|
May 25, 2002
[A bribe to be at a drug industry-consultant's disposal?]
Anders Hernborg
Lakartidningen
|
March 20, 2010
[Low-dosage ASA should not be given as primary prevention. The risk is greater than the benefit--also in high risk of cardiovascular disease]
Jan Håkansson, Anders Hernborg
Lakartidningen
|
August 28, 2014
[New recommendations means medicine to unreasonably many]
Jan Håkansson, Anders Hernborg
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
October 7, 2004
[Statins in hypertension]
Eivind Meland, Anders Hernborg
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
July 2, 2004
[Research and marketing]
Eivind Meland, Anders Hernborg
Lakartidningen
|
April 15, 2006
[Simvastatin 40 mg as secondary prophylaxis: Effective, tolerable and cost-efficient!]
Anders Hernborg, Paul Hjemdahl, Jan Håkansson
Lakartidningen
|
July 5, 2003
[A gigantic meta-analysis confirms: thiazides are best as the first choice medication in hypertension; new guidelines are necessary]
Ulf Lindblad, Anders Hernborg, Arne Melander
Lakartidningen
|
October 14, 2008
[Advertising or science?]
Jan Håkansson, Anders Hernborg, Peter Olsson
Lakartidningen
|
February 28, 2003
[Consequences of ALLHAT: Thiazides rehabilitated--time to change prescription patterns]
Anders Hernborg, Jan Håkansson, Lars Werkö, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Lakartidningen
|
October 14, 2008
[Non-biased (?) blood pressure experts criticize LFN]
Anders Hernborg
Lakartidningen
|
May 25, 2002
[A bribe to be at a drug industry-consultant's disposal?]
Anders Hernborg
Lakartidningen
|
March 20, 2010
[Low-dosage ASA should not be given as primary prevention. The risk is greater than the benefit--also in high risk of cardiovascular disease]
Jan Håkansson, Anders Hernborg
Lakartidningen
|
August 28, 2014
[New recommendations means medicine to unreasonably many]
Jan Håkansson, Anders Hernborg
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
October 7, 2004
[Statins in hypertension]
Eivind Meland, Anders Hernborg
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
July 2, 2004
[Research and marketing]
Eivind Meland, Anders Hernborg
Lakartidningen
|
April 15, 2006
[Simvastatin 40 mg as secondary prophylaxis: Effective, tolerable and cost-efficient!]
Anders Hernborg, Paul Hjemdahl, Jan Håkansson
Lakartidningen
|
July 5, 2003
[A gigantic meta-analysis confirms: thiazides are best as the first choice medication in hypertension; new guidelines are necessary]
Ulf Lindblad, Anders Hernborg, Arne Melander
Lakartidningen
|
October 14, 2008
[Advertising or science?]
Jan Håkansson, Anders Hernborg, Peter Olsson
Lakartidningen
|
February 28, 2003
[Consequences of ALLHAT: Thiazides rehabilitated--time to change prescription patterns]
Anders Hernborg, Jan Håkansson, Lars Werkö, et al.
Page
of 2